Anticoagulation reversal of dabigatran with idarurizumab in cardiac transplant recipients. More evidence to support its use.

12 May 2024 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 10 Heart Transplantation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by